No Data
No Data
Express News | J&J-New Data From Tar-200 Phase 2B Sunrise-1 Study Show 84% Complete Response Rate in Patients With High-Risk Non-Muscle-Invasive Bladder Cancer
J&J Leads H1 Healthcare Deals as Big Pharma Dealmaking Returns: Report
Express News | Rybrevant® (Amivantamab-Vmjw) Plus Chemotherapy Shows Positive Overall Survival Trend Versus Chemotherapy in Patients With Previously Treated Egfr-Mutated Lung Cancer
How Much Would It Take To Earn $1,000 A Month In Dividends With Just Four Stocks?
Pharma Stock Roundup: FDA Approves J&J's Tremfya for Ulcerative Colitis & More
How do you view the recent "hawkish" stance of the Bank of Japan executives? Goldman Sachs: The next interest rate hike may still have to wait until January next year.
Goldman Sachs believes that when evaluating the timing of interest rate hikes, it is important to consider financial market stability and inflation trends. The bank predicts that January next year will be the best time to determine whether Japan's inflation will rebound, and based on this, determine that Japan will raise interest rates in January. However, if there is significant turmoil in the financial markets, the timing of the rate hike may become uncertain.
No Data
No Data